MedPath

Donepezil effect in Executive Function of Hyperactivity Disorder

Phase 2
Completed
Conditions
attention deficit hyperactivity disorder.
Disturbance of activity and attention Attention deficit: disorder with hyperactivity hyperactivity disorder syndrome with hyperactivity Excl.: hyperkinetic disorder associated with conduct disorder
Registration Number
IRCT2016042027506N1
Lead Sponsor
Vice chancellor for research, Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

1. Age of six to twelve years; 2. DSM-5 criteria for a diagnosis of ADHD; 3. IQ above 90. Exclusion criteria: 1. an intervening physical disorder such as neurological disorders, a record of severe allergic reaction to Ritalin or Donepezil, record of heart disease; 2. a major psychiatric disease such as mood disorders, psychotic disorders, substance abuse.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.